CALLIE PECK: Open Payments
NPI 1730835687 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 38 payments from 16 companies in 2025. Trend: 2023 $467 · 2024 $559 · 2025 $773
Food & beverage: $744Education: $29
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $187 |
| Astellas Pharma US Inc | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| Janssen Biotech, Inc. | 2 | $63 |
| ARRAY BIOPHARMA INC | 8 | $46 |
| Caris MPI, Inc. | 2 | $45 |
| Incyte Corporation | 2 | $42 |
| TAIHO ONCOLOGY, INC. | 1 | $33 |
| Daiichi Sankyo Inc. | 1 | $26 |
Products named: IBRANCE, Padcev, FRUZAQLA, TALVEY, BRAFTOVI, XTANDI, SCEMBLIX, MI CANCER SEEK.
Industry payments across GA — which companies pay providers there.
